NovaQuest Capital Management, the corporate venturing unit which was spun off from US-based healthcare provider Quintiles Transnational in 2010, has raised $80 million for a new fund, NovaQuest Co- Investment Fund I, LP, according to a regulatory filing on 3 May.
Novaquest’s existing fund, NovaQuest Pharma Opportunities Fund III, LP, launched in November 2010, had raised $426.1m against its $500m target offering, as of its latest regulatory filing on 14 November 2012. In the most recent investment for the fund,…
